Curetis Goes Dutch With Dual Euronext Listing For IPO
This article was originally published in Clinica
Executive Summary
German molecular diagnostics specialist Curetis AG is to become a newly incorporated Dutch holding, Curetis N.V., and list its shares on the Euronext stock exchanges in Amsterdam and Brussels. The announcement comes just under three months after the company told Clinica it planned to turn to the public markets for its next fundraising round.